BON / Bon Natural Life Limited - Depositi SEC, Relazione annuale, dichiarazione di delega

Bon Natural Life Limited

Statistiche di base
CIK 1816815
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bon Natural Life Limited
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
August 5, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number 001-40517 B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sh

July 21, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaa

July 21, 2025 EX-10.1

Xi’an App-Chem Bio (Tech) and Beijing Huahai Keyuan Sales Cooperation Agreement for Natural Weight Loss

Exhibit 10.1 Xi’an App-Chem Bio (Tech) and Beijing Huahai Keyuan Sales Cooperation Agreement for Natural Weight Loss Products Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Date:July 4, 2025 Party B: Beijing Huahai Keyuan Technology Co., Ltd. Place of signing:Xi’an Agreement No.:BONHHKY20250704 Party A (Nasdaq: BON) is a supplier of natural health bioactive ingredients and health solutions, speciali

July 21, 2025 EX-99.1

BON Announces $22 Million

Exhibit 99.1 BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd XI’AN, China, July 21, 2025 (PR NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive

July 11, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaa

July 2, 2025 EX-99.1

Bon Announces Breakthrough Order for $16 Million Gut-Health Products

Exhibit 99.1 Bon Announces Breakthrough Order for $16 Million Gut-Health Products XI’AN, China, July 2, 2025 (PR NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solutions provider in the natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a

July 2, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaa

July 2, 2025 EX-10.1

Xi’an App-Chem Bio (Tech) and Beijing Huahai Keyuan Sales Cooperation Agreement for Natural Prebiotic Series Health Products

Exhibit 10.1 Xi’an App-Chem Bio (Tech) and Beijing Huahai Keyuan Sales Cooperation Agreement for Natural Prebiotic Series Health Products Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Date:June 10, 2025 Party B: Beijing Huahai Keyuan Place of signing:Xi’an Technology Co., Ltd. Agreement No.:BONHHKY20250610 Party A (Nasdaq: BON) is a supplier of natural health bioactive ingredients and health soluti

June 16, 2025 EX-99.1

Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.

Exhibit 99.1 Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd. XI’AN China, June 16, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“Bon” or the “Company”), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youl

June 16, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaa

June 16, 2025 EX-10.1

Xi an App-Chem Bio (Tech) Co., Ltd. and Tianjin MERRILL-YOULI Trading Co., Ltd.Cooperation Agreement for Clary Sage Extract Products

Exhibit 10.1 Xi an App-Chem Bio (Tech) Co., Ltd. and Tianjin MERRILL-YOULI Trading Co., Ltd.Cooperation Agreement for Clary Sage Extract Products Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Date: May 26, 2025 Party B:Tianjin MERRILL-YOULI Trading Co., Ltd. Place of signing: Xi’an Agreement No.:BONMRBL20250526 Party A (Nasdaq Symbol: BON), a leading bio-based ingredient solutions provider in the n

June 3, 2025 EX-99.1

BON Announces Share Repurchase Program for up to US$1.0 Million

Exhibit 99.1 BON Announces Share Repurchase Program for up to US$1.0 Million XI’AN, China, June 3, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced its board of directors approved a share repurchase program pursuant to which the Company may purchase

June 3, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaa

May 22, 2025 EX-99.1

BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade

Exhibit 99.1 BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade XI’AN, China, May 22, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales coopera

May 22, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaan

May 22, 2025 EX-10.1

Xi`an App-Chem Bio (Tech) and Shanghai Risesun International Trade Sales Cooperation Agreement for Tea Pigment Series Health Products Party A: Xi`an App-Chem Bio (Tech) Co., Ltd. Date: May 12, 2025 Party B: Shanghai Risesun International Trade Co., L

Exhibit 10.1 Xi`an App-Chem Bio (Tech) and Shanghai Risesun International Trade Sales Cooperation Agreement for Tea Pigment Series Health Products Party A: Xi`an App-Chem Bio (Tech) Co., Ltd. Date: May 12, 2025 Party B: Shanghai Risesun International Trade Co., Ltd. Place: Xi’an Agreement No.: BONYS20250512 Party A (Nasdaq : BON), a globally established provider of natural health bioactive ingredi

May 16, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaan

May 16, 2025 EX-10.1

Postbiotics Health Product Line Cooperation Agreement

Exhibit 10.1 Postbiotics Health Product Line Cooperation Agreement Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Date: Apr. 15th, 2025 Party B: Beijing Huahai Keyuan (Tech) Co., Ltd. Place: Xi’an Agreement No.: BONHHKY20250415 Party A (Nasdaq: BON) is a Nasdaq-listed supplier of natural bioactive ingredients and health solutions. Xi’an App-Chem specializes in researching, developing, producing, and

May 16, 2025 EX-99.2

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

Exhibit 99.2 BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with Beijing Hua

May 5, 2025 EX-99.1

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications

Exhibit 99.1 Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications XI’AN, China, May 2, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, 2025, the Company received a letter (the “Notification Lett

May 5, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaan

April 23, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

April 16, 2025 CORRESP

Mark E. Crone

Mark E. Crone Managing Partner [email protected] April 16, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Tana Harkins Lynn Dicker Daniel Crawford Laura Crotty Re: Bon Natural Life Limited Form 20-F for Fiscal Year Ended September 30, 2025 File No. 001-40517 Dear Sir and Madam: On behalf of Bon Na

April 16, 2025 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A Amendment No. 1 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A Amendment No. 1 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

April 11, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

April 11, 2025 EX-10.1

Apple Polyphenol Project Cooperation Agreement

Exhibit 10.1 Apple Polyphenol Project Cooperation Agreement Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Agreement No.: BONYS20250219-01 Party B: Shanghai Yunsheng International Trading Co., Ltd. Place: Xi’an Date: 2025.02.19 Xi’an App-Chem Bio(Tech) Co., Ltd. (NASDAQ: BON) is a supplier of natural health bioactive ingredients and health solutions. Party A specializes in the research, development,

April 11, 2025 EX-99.1

BON Announces Apple Polyphenol Commercial Order Signed

Exhibit 99.1 BON Announces Apple Polyphenol Commercial Order Signed XI’AN, China, April 11, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, China’s premier functional ingredient

April 3, 2025 EX-3.1

THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Fourth Amended and Restated Memorandum of Association Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) FOURTH AMENDED AND RESTAT

Exhibit 3.1 THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Fourth Amended and Restated Memorandum of Association of Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) FOURTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated [date]) 1. Name The name

April 3, 2025 EX-99.1

Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING

Exhibit 99.1 Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING Notice is hereby given that the extraordinary general meeting (the Meeting) of Bon Natural Life Limited, a Cayman Islands exempted company with limited liability (the Company) will be held at Room 601, Block C, Gazelle Valley, No.69, Jinye Road, High-Tech Zone, Xi’an, Shaanxi, Ch

April 3, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

April 3, 2025 EX-3.2

THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Fourth Amended and Restated Articles of Association Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS REVISED) FOURTH AMENDED AND RESTATED

Exhibit 3.2 THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Fourth Amended and Restated Articles of Association of Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS REVISED) FOURTH AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated [date]) 1. Table A The Table

April 2, 2025 EX-FILING FEES

Calculation of Filing Fee Tables Form S-8 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(2) Proposed Maximum Offering Price per Share(1) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A Ordinary Shares, par value $0.

April 2, 2025 EX-10.1

BON NATURAL LIFE Limited 2024 EQUITY INCENTIVE PLAN TABLE OF CONTENTS

Exhibit 10.1 Appendix 2 BON NATURAL LIFE Limited 2024 EQUITY INCENTIVE PLAN TABLE OF CONTENTS Page I. ESTABLISHMENT, OBJECTIVES AND DURATION 3 II. DEFINITIONS 3 III. ADMINISTRATION 7 IV. SHARES SUBJECT TO THE PLAN AND MAXIMUM AWARDS 7 V. ELIGIBILITY AND PARTICIPATION 9 VI. STOCK OPTIONS 9 VII. STOCK APPRECIATION RIGHTS 11 VIII. RESTRICTED STOCK 12 IX. RESTRICTED STOCK UNITS 15 X. PERFORMANCE UNITS

April 2, 2025 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organization) Not applicable (I.R.S. Employer Identification No.) C601, Gazelle Valley, No.69 Jinye Road. Xi’an Hi-tech

March 18, 2025 424B4

BON NATURAL LIFE LIMITED Up to 8,333,332 Ordinary Units (Each Contains One Class A Ordinary Share, One Series A Warrant to Purchase One Class A Ordinary Share and One Series B Warrant to Purchase One Class A Ordinary Share) Up to 8,333,332 Pre-Funded

Filed pursuant to Rule 424(b)(4) Registration Statement No. 333-283333 BON NATURAL LIFE LIMITED Up to 8,333,332 Ordinary Units (Each Contains One Class A Ordinary Share, One Series A Warrant to Purchase One Class A Ordinary Share and One Series B Warrant to Purchase One Class A Ordinary Share) Up to 8,333,332 Pre-Funded Units (Each Contains One Pre-Funded Warrant, One Series A Warrant to Purchase

March 17, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

March 17, 2025 EX-4.3

SERIES A CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.3 SERIES A CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [●] Issue Date: [●] THIS SERIES A CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2025 (the “Initial Ex

March 17, 2025 EX-10.12

PLACEMENT AGENCY AGREEMENT

Exhibit 10.12 PLACEMENT AGENCY AGREEMENT March 16, 2025 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY, 10019 Ladies and Gentlemen: Subject to the terms and conditions of this agreement (this “Agreement”) and the Transaction Documents (as defined below), Bon Natural Life Limited, a Cayman Islands exempted company (the “Company”), hereby agrees to sell an aggregate of 8,333,3

March 17, 2025 EX-10.11

SECURITIES PURCHASE AGREEMENT

Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”), dated as of March 16, 2025, is by between Bon Natural Life Limited, a company organized under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHER

March 17, 2025 EX-4.5

PRE-FUNDED CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.5 PRE-FUNDED CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [•] Issue Date: [•] THIS PRE-FUNDED CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [•] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “I

March 17, 2025 EX-4.4

SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.4 SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [●] Issue Date: [●] THIS SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2025 (the “Initial Ex

March 17, 2025 EX-99.1

Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering

Exhibit 99.1 Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering XI’AN, China, March 17, 2025 /PRNewswire/— Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has priced a best efforts offering of units as described below for a

March 14, 2025 CORRESP

Bon Natural Life Limited C601, Gazelle Valley, No.69 Jinye Road. Xi’an Hi-tech Zone, Xi’an, China

Bon Natural Life Limited C601, Gazelle Valley, No.69 Jinye Road. Xi’an Hi-tech Zone, Xi’an, China March 14, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Bon Natural Life Limited Registration Statement on Form F-1 File No. 333- 283333 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1

March 14, 2025 CORRESP

[Signature Page to Follow]

March 14, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bon Natural Life Limited Registration Statement on Form F-1, as amended File No. 333-283333 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amend

March 13, 2025 F-1/A

As filed with the Securities and Exchange Commission on March 13, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 4 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limite

As filed with the Securities and Exchange Commission on March 13, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

March 13, 2025 CORRESP

Mark E. Crone

Mark E. Crone Managing Partner [email protected] March 13, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Daniel Crawford Joe McCann John Coleman Re: Bon Natural Life Limited Amendment No. 4 to Registration Statement on Form F-1 Submitted March 3, 2025 File No. 333-283333 Dear Sir and Madam: On be

March 13, 2025 EX-10.12

PLACEMENT AGENCY AGREEMENT

Exhibit 10.12 PLACEMENT AGENCY AGREEMENT [●], 2025 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY, 10019 Ladies and Gentlemen: Subject to the terms and conditions of this agreement (this “Agreement”) and the Transaction Documents (as defined below), Bon Natural Life Limited, a Cayman Islands exempted company (the “Company”), hereby agrees to sell an aggregate of [●] units (t

March 6, 2025 CORRESP

Mark E. Crone

Mark E. Crone Managing Partner [email protected] March 5, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Daniel Crawford Joe McCann John Coleman Re: Bon Natural Life Limited Amendment No. 3 to Registration Statement on Form F-1 Submitted March 3, 2025 File No. 333-283333 Dear Sir and Madam: On beh

March 3, 2025 EX-FILING FEES

Calculation of Filing Fee Tables Form F-1 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) (2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) (2) Fee Rate Amount of Registration Fee Fees to be Paid Equity Ordinary Units consisting of: Rule 457(o) — — $ 12,000,000 0.

March 3, 2025 F-1/A

As filed with the Securities and Exchange Commission on March 3, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 3 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited

As filed with the Securities and Exchange Commission on March 3, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

March 3, 2025 CORRESP

Mark E. Crone

Mark E. Crone Managing Partner [email protected] March 3, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Daniel Crawford Joe McCann John Coleman Re: Bon Natural Life Amendment No. 2 to Registration Statement on Form F-1 Submitted February 18, 2025 File No. 333-283333 Dear Sir and Madam: On behalf

February 28, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an,

February 28, 2025 EX-3.1

THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Third Amended and Restated Memorandum of Association Bon Natural Life Limited (adopted by special resolutions dated January 16, 2025) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) THIRD AMENDED AN

Exhibit 3.1 THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Third Amended and Restated Memorandum of Association of Bon Natural Life Limited (adopted by special resolutions dated January 16, 2025) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) THIRD AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated January 16, 2025

February 18, 2025 CORRESP

Mark E. Crone

Mark E. Crone Managing Partner [email protected] February 18, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Daniel Crawford Joe McCann John Coleman Re: Bon Natural Life Amendment No. 1 to Registration Statement on Form F-1 Submitted January 16, 2025 File No. 333-283333 Dear Sir and Madam: On beha

February 18, 2025 EX-3.1

THE CAYMAN ISLANDS THE COMPANIES ACT (AS REVISED) THIRD AMENDED AND RESTATED ARTICLES OF ASSOCIATION Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated January 16, 2025) (as filed with the Registry of Companies of the Caym

Exhibit 3.1 THE CAYMAN ISLANDS THE COMPANIES ACT (AS REVISED) THIRD AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated January 16, 2025) (as filed with the Registry of Companies of the Cayman Islands on January 21, 2025) 1. Table A The Table ‘A’ in the First Schedule of The Companies Act (As Amended) shall not apply to thi

February 18, 2025 F-1/A

As filed with the Securities and Exchange Commission on February 18, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Lim

As filed with the Securities and Exchange Commission on February 18, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

February 18, 2025 EX-4.4

SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.4 SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [●] Issue Date: [●] THIS SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2025 (the “Initial Ex

January 28, 2025 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

January 17, 2025 F-1/A

As filed with the Securities and Exchange Commission on January 16, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limi

As filed with the Securities and Exchange Commission on January 16, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

January 17, 2025 EX-FILING FEES

Calculation of Filing Fee Tables Form F-1 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) (2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) (2) Fee Rate Amount of Registration Fee Fees to be Paid Equity Ordinary Units consisting of: Rule 457(o) — — $ 10,000,000 0.

January 17, 2025 EX-3.2

THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Third Amended and Restated Articles of Association Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS REVISED) THIRD AMENDED AND RESTATED A

Exhibit 3.2 THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Third Amended and Restated Articles of Association of Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS REVISED) THIRD AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated [date]) 1. Table A The Table ‘

January 17, 2025 EX-4.3

SERIES A CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.3 SERIES A CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [●] Issue Date: [●] THIS SERIES A CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2025 (the “Initial Ex

January 17, 2025 EX-10.12

PLACEMENT AGENCY AGREEMENT

Exhibit 10.12 PLACEMENT AGENCY AGREEMENT [●], 2025 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY, 10019 Ladies and Gentlemen: Subject to the terms and conditions of this agreement (this “Agreement”) and the Transaction Documents (as defined below), Bon Natural Life Limited, a Cayman Islands exempted company (the “Company”), hereby agrees to sell an aggregate of [●] units (t

January 17, 2025 EX-4.4

SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.4 SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [●] Issue Date: [●] THIS SERIES B CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2025 (the “Initial Ex

January 17, 2025 EX-4.5

PRE-FUNDED CLASS A ORDINARY SHARE PURCHASE WARRANT

Exhibit 4.5 PRE-FUNDED CLASS A ORDINARY SHARE PURCHASE WARRANT Warrant Shares: [•] Issue Date: [•] THIS PRE-FUNDED CLASS A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [•] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “I

January 17, 2025 EX-10.11

SECURITIES PURCHASE AGREEMENT

Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”), dated as of [●], 2025, is by between Bon Natural Life Limited, a company organized under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS,

January 16, 2025 CORRESP

Mark E. Crone

Mark E. Crone Managing Partner [email protected] January 16, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Daniel Crawford Joe McCann John Coleman Re: Bon Natural Life Amendment No. 1 to Registration Statement on Form F-1 Submitted November 19, 2024 File No. 333-283333 Dear Sir and Madam: On beha

January 6, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number 001-40517

6-K 1 form6-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-T

January 6, 2025 EX-99.1

Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING

Exhibit 99.1 Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING Notice is hereby given that the extraordinary general meeting (the Meeting) of Bon Natural Life Limited, a Cayman Islands exempted company with limited liability (the Company) will be held at Room 601, Block C, Gazelle Valley, No.69, Jinye Road,High-Tech Zone, Xi’an, Shaanxi, Chi

January 6, 2025 EX-99.3

Appendix 1 Third amended and restated memorandum and articles of association THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Third Amended and Restated Memorandum of Association Bon Natural Life Limited (adopted by special resolutions dated [date])

Exhibit 99.3 Appendix 1 Third amended and restated memorandum and articles of association THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Third Amended and Restated Memorandum of Association of Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) THIRD AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Bon Natural Life Limited (t

January 6, 2025 EX-99.2

Bon Natural Life Limited Registered Company No 358246 (the Company) Proxy Form

Exhibit 99.2 Bon Natural Life Limited Registered Company No 358246 (the Company) Proxy Form I/We of being a member/members of the Company and the holder/holders of (number and class of shares) appoint as my/our proxy of at the extraordinary general meeting of the Company to be held at Room 601, Block C, Gazelle Valley, No.69, Jinye Road,High-Tech Zone, Xi’an, Shaanxi, China on 16 January 2025 at 1

January 3, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, S

January 3, 2025 EX-10.3

Asset Selling Agreement Transferor: Xi`an App-Chem Bio (Tech) Co., Ltd. Transferee: Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. Date: September 30, 2024 第 1 页 共 6 页

Exhibit 10.3 Asset Selling Agreement Transferor: Xi`an App-Chem Bio (Tech) Co., Ltd. Transferee: Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. Date: September 30, 2024 第 1 页 共 6 页 Parties to the Agreement: Transferor: Xi’an App-Chem Bio (Tech) Co., Ltd. ( “Party A”) Address: Legal Representative: Tel: Transferee: Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. (“Party B”) Address: Legal Represen

January 3, 2025 EX-10.2

Equity Transfer Agreement

Exhibit 10.2 Equity Transfer Agreement Transferor: Tea Essence Limited (hereinafter referred to as “Party A”) Transferee: Tea Essence Health Tech (HangZhou) Co.,Ltd (hereinafter referred to as “Party B”) WHEREAS: Party A lawfully holds 100% of the equity in Xi’an Youpincui Biotechnology Co., Ltd. (hereinafter referred to as “the Company”). Now Party A decides to transfer the equity it holds in the

January 3, 2025 EX-10.1

Equity Transfer Agreement

Exhibit 10.1 Equity Transfer Agreement Transferor: Tea Essence Limited (hereinafter referred to as “Party A”) Transferee: Tea Essence Health Tech (HangZhou) Co.,Ltd. (hereinafter referred to as “Party B”) WHEREAS: Party A lawfully holds 100% of the equity in Xi’an Cell and Molecule Information Technology Co., Ltd.(hereinafter referred to as “the Company”). Now Party A decides to transfer the equit

January 3, 2025 EX-10.4

EX-10.4

Exhibit 10.4

December 18, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an,

November 19, 2024 F-1

As filed with the Securities and Exchange Commission on November 19, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of

As filed with the Securities and Exchange Commission on November 19, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

November 19, 2024 EX-FILING FEES

Calculation of Filing Fee Tables Form F-1 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price (1) Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid Equity Ordinary Shares, $0.

October 31, 2024 DRS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter)

This Draft Registration Statement is confidentially submitted to the U.S. Securities and Exchange Commission pursuant to Section 106(a) of the Jumpstart Our Business Startups Act of 2012 on October 30, 2024 and is not being filed publicly under the Securities Act of 1933, as amended. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE S

October 29, 2024 EX-10.1

BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT

Exhibit 10.1 BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT This Director Service Agreement (the “Agreement”) is made and entered into as of October 28, 2024, by and between Bon Natural Life Limited, a Cayman Islands corporation (the “Company”), and Jing Liu, a non-individual (the “Director”). I. SERVICES A. Service on the Board of Directors. The Director has been appointed as a Director of t

October 29, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, S

October 11, 2024 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A Amendment No. 2 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A Amendment No. 2 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

October 11, 2024 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A Amendment No. 1 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A Amendment No. 1 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

October 4, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number 001-4051

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an,

October 4, 2024 EX-10.1

Asset Selling Agreement Transferor: Xi`an App-Chem Bio (Tech) Co., Ltd. Transferee: Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. Date: September 30, 2024

Exhibit 10.1 Asset Selling Agreement Transferor: Xi`an App-Chem Bio (Tech) Co., Ltd. Transferee: Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. Date: September 30, 2024 第 1 页 共 7 页 Parties to the Agreement: Transferor: Xi’an App-Chem Bio (Tech) Co., Ltd. ( “Party A”) Address: Legal Representative: Tel: Transferee: Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. (“Party B”) Address: Legal Represen

September 27, 2024 EX-99.1

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) As of March 31, 2024 September 30, 2023 ASSETS CURRENT ASSETS Cash $ 717,879 $ 112,751 Short-term investments - 65 Accounts receivable, net 8,108,271 4,602,466 Inventories, net 1,437,180 987,287 Advance to suppliers, net 15,414,883 15,117,191 Acquisition deposit 1,000,000 1,000,000 Prepaid expe

September 27, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number 001-4051

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) C601, Gazelle Valley, No.69 Jinye Road Xi’an Hi-Tech Zone, Xi’an, China Peo

September 12, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number 001-40517 B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sh

September 12, 2024 EX-10.1

ORDINARY SHARE PURCHASE AGREEMENT

Exhibit 10.1 ORDINARY SHARE PURCHASE AGREEMENT This Ordinary Share Purchase Agreement (this “Agreement”) is entered into effective as September 9, 2024 (the “Execution Date”), by and between Bon Natural Life Ltd., a Cayman Islands exempted company (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”). WHEREAS, the parties desire that, upon the terms and

May 20, 2024 EX-10.2

WARRANT to Purchase Ordinary Shares of Bon Natural Life Limted a Cayman Islands Exempted Company

Exhibit 10.2 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS SUCH SALE, TRANSFER, PLEDGE OR HYPOTHECATION IS IN ACCORDANCE WITH SUCH ACT AND APPLICABLE STATE SECURITIES LAWS. Warrant No. No. of

May 20, 2024 EX-10.1

SUBSCRIPTION AGREEMENT BON NATURAL LIFE LIMITED

Exhibit 10.1 SUBSCRIPTION AGREEMENT BON NATURAL LIFE LIMITED Bon Natural Life Limited, a Cayman Islands exempted company (hereinafter the “Company”) and the undersigned (hereinafter the “Subscriber”) agree as follows: WHEREAS: A. The Company desires to issue a total of US$5,600,000 worth of ordinary shares of the Company, par value $0.001 per share (the “Shares”), at the Subscription Price as defi

May 20, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaan

May 14, 2024 EX-99.1

Bon Natural Life Limited Announces Brand Strategic Cooperation with Guangdong JUWO

Exhibit 99.1 Bon Natural Life Limited Announces Brand Strategic Cooperation with Guangdong JUWO XI’AN, China, May 14, 2024 /GLOBE NEWSWIRE/ — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that its operating subsidiary, Xi’an App-Chem Bio (Tech) Co., Ltd., re

May 14, 2024 EX-10.1

Brand Authorization Agreement Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Party B: Guangdong JUWO Trading Co., Ltd. May 8, 2024 At Shenzhen

Exhibit 10.1 Brand Authorization Agreement Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Party B: Guangdong JUWO Trading Co., Ltd. May 8, 2024 At Shenzhen This Agreement is made and entered into by and between the Parties hereto at Shenzhen on May 8, 2024. Parties: (1) App-Chem: Xi’an App-Chem Bio (Tech) Co., Ltd. (hereinafter referred to as “Party A”); (2) Project Company: Guangdong JUWO Trading C

May 14, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Shaan

May 6, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

April 19, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

April 8, 2024 EX-3.1

EX-3.1

Exhibit 3.1

April 8, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

March 14, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sha

February 23, 2024 EX-99.1

Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING

Exhibit 99.1 Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING Notice is hereby given that the extraordinary general meeting (the Meeting) of Bon Natural Life Limited, a Cayman Islands exempted company with limited liability (the Company) will be held at Room 601, Block C, Gazelle Valley, No.69, Jinye Road, High-Tech Zone, Xi’an, Shaanxi, Ch

February 23, 2024 EX-4.1

BON NATURAL LIFE Limited 2024 EQUITY INCENTIVE PLAN TABLE OF CONTENTS

Exhibit 4.1 BON NATURAL LIFE Limited 2024 EQUITY INCENTIVE PLAN TABLE OF CONTENTS Page I. ESTABLISHMENT, OBJECTIVES AND DURATION 3 II. DEFINITIONS 3 III. ADMINISTRATION 7 IV. SHARES SUBJECT TO THE PLAN AND MAXIMUM AWARDS 7 V. ELIGIBILITY AND PARTICIPATION 9 VI. STOCK OPTIONS 9 VII. STOCK APPRECIATION RIGHTS 11 VIII. RESTRICTED STOCK 12 IX. RESTRICTED STOCK UNITS 15 X. PERFORMANCE UNITS AND PERFORM

February 23, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an,

February 23, 2024 EX-3.1

THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Second Amended and Restated Memorandum of Association Bon Natural Life Limited (adopted by special resolutions dated March 9, 2024) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) SECOND AMENDED AND

Exhibit 3.1 THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Second Amended and Restated Memorandum of Association of Bon Natural Life Limited (adopted by special resolutions dated March 9, 2024) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) (adopted by special resolutions dated March 9, 2024) 1.

February 9, 2024 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

January 30, 2024 NT 20-F

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 001-40517 Notification of Late Filing (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report

December 13, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an,

November 28, 2023 EX-99.1

Bon Natural Life Limited Incentive Compensation Recovery Policy

Exhibit 99.1 Bon Natural Life Limited Incentive Compensation Recovery Policy Effective Date: November 22, 2023 1. Purpose. The purpose of the Bon Natural Life Limited Incentive Compensation Recovery Policy (this “Policy”) is to provide for the recovery of certain Incentive-Based Compensation in the event of an Accounting Restatement. This Policy is intended to comply with, and to be administered a

November 28, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an,

October 12, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, S

October 5, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 001-40517

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, S

October 5, 2023 EX-10.1

BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT

Exhibit 10.1 BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT This Director Service Agreement (the “Agreement”) is made and entered into as of October 3, 2023, by and between Bon Natural Life Limited, a Cayman Islands corporation (the “Company”), and Jing Chen, an individual (the “Director”). I. SERVICES A. Service on the Board of Directors. The Director has been appointed as an Independent Dir

October 5, 2023 EX-10.2

BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT

Exhibit 10.2 BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT This Director Service Agreement (the “Agreement”) is made and entered into as of October 3, 2023, by and between Bon Natural Life Limited, a Cayman Islands corporation (the “Company”), and Zhixiang Gao, an individual (the “Director”). I. SERVICES A. Service on the Board of Directors. The Director has been appointed as an Independent

October 5, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 CommissionFile Number 001-40517 B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 CommissionFile Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sh

October 5, 2023 EX-99.1

Memorandum of Understanding

Exhibit 99.1 合作谅解备忘录 Memorandum of Understanding 甲方:Bon Natural Life Limited(NASDAQ: BON)(“BON”) Party A:Bon Natural Life Limited(NASDAQ: BON)(“BON”) 乙方:广东酱王国际控股有限公司(“酱王”) Party B: Guangdong Jiangwang International Holdings Limited (“Jiangwang”) BON是一家全球领先的致力于功能食品、功能性个人护理行业天然活性成分的生物制造,以及相关健康解决方案开发的高科技生物技术公司,公司于2021年6月在纳斯达克上市。基于中国庞大的白酒市场规模和持续增长趋势,公司希望进入该领域,并关注白酒相关健康产品。 BON, getting listed on NASDAQ

September 11, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-4051

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) C601, Gazelle Valley, No.69 Jinye Road Xi’an Hi-Tech Zone, Xi’an, China Peo

September 11, 2023 EX-99.2

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.2 1H-2023 Revenue increases by 3.4% to 14.1 million XI’AN, China, Sep. 11, 2023 (GLOBE NEWSWIRE) – Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year financial results for the six months ended March 31, 2023. 1H-2023 Financial Highlights

September 11, 2023 EX-99.1

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) As of March 31, 2023 September 30, 2022 ASSETS CURRENT ASSETS Cash $ 542,272 $ 840,861 Accounts receivable, net 9,260,407 6,784,307 Inventories, net 1,803,374 1,722,120 Advance to suppliers, net 7,644,920 4,091,990 Acquisition deposit 1,000,000 1,000,000 Prepaid expenses and other current asset

September 7, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-4051

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People

August 9, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-40517 B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sh

August 4, 2023 EX-10.1

BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT

Exhibit 10.1 BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT This Director Service Agreement (the “Agreement”) is made and entered into as of August 3, 2023, by and between Bon Natural Life Limited, a Cayman Islands corporation (the “Company”), and Jianjun Gao, an individual (the “Director”). I. SERVICES A. Service on the Board of Directors. The Director has been appointed as an Independent Di

August 4, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-40517 B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi’an, Sh

August 4, 2023 EX-10.2

BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT

Exhibit 10.2 BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT This Director Service Agreement (the “Agreement”) is made and entered into as of August 3, 2023, by and between Bon Natural Life Limited, a Cayman Islands corporation (the “Company”), and Yingchun Xue, an individual (the “Director”). I. SERVICES A. Service on the Board of Directors. The Director has been appointed as a Director of th

July 7, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s Re

June 30, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s Re

June 15, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s Re

May 25, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s Rep

May 15, 2023 20-F/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Amendment No. 1 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Amendment No. 1 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

May 15, 2023 CORRESP

Joe Laxague

Joe Laxague Partner [email protected] VIA EDGAR May 15, 2023 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Attn: Arzhang Navai Re: Bon Natural Life Limited Form 20-F for the Fiscal Year Ended September 30, 2022 Filed February 10, 2023 File No. 001-40517 Dear Mr. Navai: We write on behalf of Bon Natural Life Limited (the “Company”) in response to comments by t

April 21, 2023 EX-10.1

English Translation of Employment Agreement by and between Wallace Lee and Bon Natural Life Limited, dated April 17, 2023

Exhibit 10.1 Labor Contract Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Address: Room C601, Entrepreneurship Research and Development Park, No. 69, Jinye Road, Xi’an Hi-Tech Industries Development Zone, China Telephone:029-88346301 Post Code: 710077 Party B: Wallace Lee ID Number: H00250524 Address: Room211 Block6 Beijing Sugar Cube, Huosi Road, Houshayu, Shunyi District, Beijing Telephone:150108

April 21, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s R

April 5, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number 001-40517 BO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s R

April 5, 2023 EX-10.1

Form of Subscription Agreement

Exhibit 10.1 SUBSCRIPTION AGREEMENT BON NATURAL LIFE LIMITED Bon Natural Life Limited, a Cayman Islands exempted company (hereinafter the “Company”) and the undersigned (hereinafter the “Subscriber”) agree as follows: WHEREAS: A. Pursuant to the Registration Statement on Form F-3 (File No. 333-267116) filed by the Company with the Securities and Exchange Commission (the “Commission”) and declared

April 5, 2023 EX-10.2

Form of Warrant

Exhibit 10.2 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS SUCH SALE, TRANSFER, PLEDGE OR HYPOTHECATION IS IN ACCORDANCE WITH SUCH ACT AND APPLICABLE STATE SECURITIES LAWS. Warrant No. No. of

March 31, 2023 424B5

$3,000,000 worth of Ordinary Shares and Warrants Bon Natural Life Limited

Filed Pursuant to Rule 424(b)(5) Registration No. 333-267116 Prospectus Supplement (to Prospectus Dated November 22, 2022) $3,000,000 worth of Ordinary Shares and Warrants Bon Natural Life Limited Pursuant to this prospectus supplement and the accompanying prospectus, Bon Natural Life Limited is offering directly to the public up to $3,000,000 worth of ordinary shares of the Company, par value $0.

February 10, 2023 20-F

Form 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

January 31, 2023 NT 20-F

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: 001-40517 Notification of Late Filing (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR For Period Ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report

January 27, 2023 424B5

2,750,000 Ordinary Shares Bon Natural Life Limited

Filed Pursuant to Rule 424(b)(5) Registration No. 333-267116 Prospectus Supplement (to Prospectus Dated November 22, 2022) 2,750,000 Ordinary Shares Bon Natural Life Limited This prospectus supplement relates to the offer and resale by certain selling stockholders of an aggregate 2,750,000 ordinary shares, $0.0001par value per share (the “Ordinary Shares”), of Bon Natural Life Limited, all of whic

January 20, 2023 EX-10.1

Form of Subscription Agreement

Exhibit 10.1 SUBSCRIPTION AGREEMENT BON NATURAL LIFE LIMITED Bon Natural Life Limited, a Cayman Islands exempted company (hereinafter the “Company”) and the undersigned (hereinafter the “Subscriber”) agree as follows: WHEREAS: A. The Company desires to issue a total of US$2,200,000 worth of ordinary shares of the Company, par value $0.0001 per share (the “Shares”), at the Subscription Price as def

January 20, 2023 EX-10.2

Form of Warrant

Exhibit 10.2 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS SUCH SALE, TRANSFER, PLEDGE OR HYPOTHECATION IS IN ACCORDANCE WITH SUCH ACT AND APPLICABLE STATE SECURITIES LAWS. Warrant No. No. of

January 20, 2023 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’s

December 27, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity(1) Ordinary Shares of Common Stock, $0.

December 27, 2022 EX-4.1

Bon Natural Life 2022 equity Incentive Plan

Exhibit 4.1 BON NATURAL LIFE Limited 2022 EQUITY INCENTIVE PLAN 1 TABLE OF CONTENTS Page I. ESTABLISHMENT, OBJECTIVES AND DURATION 3 II. DEFINITIONS 3 III. ADMINISTRATION 7 IV. SHARES SUBJECT TO THE PLAN AND MAXIMUM AWARDS 7 V. ELIGIBILITY AND PARTICIPATION 9 VI. STOCK OPTIONS 9 VII. STOCK APPRECIATION RIGHTS 11 VIII. RESTRICTED STOCK 12 IX. RESTRICTED STOCK UNITS 15 X. PERFORMANCE UNITS AND PERFO

December 27, 2022 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organization) Not applicable (I.R.S. Employer Identification No.) C601, Gazelle Valley, No.69 Jinye Road. Xi’an Hi-tech

December 2, 2022 CORRESP

VIA EDGAR

VIA EDGAR December 2, 2022 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Division of Corporation Finance Washington, D.

November 30, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’

November 22, 2022 CORRESP

Joe Laxague

Joe Laxague Partner [email protected] Mason Allen Of Counsel [email protected] VIA EDGAR November 22, 2022 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Attn: Abby Adams Re: Bon Natural Life Limited Amendment No. 2 to Registration Statement on Form F-3 Filed October 31, 2022 File No. 333-267116 Dear Ms. Adams: We write on behalf of Bon Natural Life Lim

November 22, 2022 F-3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3/A Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter)

Registration No. 333-267116 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3/A Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 25F,

November 8, 2022 EX-3.1

Amended and Restated Memorandum and Articles of Association of the Registrant, as currently in effect(4)

Exhibit 3.1 THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) Amended and Restated Memorandum of Association of Bon Natural Life Limited (adopted by special resolutions dated [date]) THE CAYMAN ISLANDS THE COMPANIES ACT (AS AMENDED) AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Bon Natural Life Limited (the “Company”) 1. Name The name of the Company is Bon Natural Life Limited. 2. Registered O

November 8, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant’s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-Tech Zone, Xi’an, China People’

November 8, 2022 EX-4.1

2022 Equity Incentive Plan

EX-4.1 3 ex4-1.htm Exhibit 4.1 BON NATURAL LIFE Limited 2022 EQUITY INCENTIVE PLAN 1 TABLE OF CONTENTS Page I. ESTABLISHMENT, OBJECTIVES AND DURATION 3 II. DEFINITIONS 3 III. ADMINISTRATION 7 IV. SHARES SUBJECT TO THE PLAN AND MAXIMUM AWARDS 7 V. ELIGIBILITY AND PARTICIPATION 9 VI. STOCK OPTIONS 9 VII. STOCK APPRECIATION RIGHTS 11 VIII. RESTRICTED STOCK 12 IX. RESTRICTED STOCK UNITS 15 X. PERFORMA

November 8, 2022 EX-99.1

Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING

Exhibit 99.1 Bon Natural Life Limited Registered Company No 358246 (the Company) NOTICE OF EXTRAODINARY GENERAL MEETING Notice is hereby given that the extraordinary general meeting (the Meeting) of Bon Natural Life Limited, a Cayman Islands exempted company with limited liability (the Company) will be held at 25F, Block C, Rongcheng Yungu, Keji 3rd Road, Yanta District, Xian City, Shaanxi Provinc

October 31, 2022 CORRESP

VIA EDGAR

VIA EDGAR October 31, 2022 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 31, 2022 F-3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3/A Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter)

Registration No. 333-267116 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3/A Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 25F,

October 18, 2022 EX-16.1

Letter from Friedman, LLP to the Securities and Exchange Commission

Exhibit 16.1 October 18, 2022 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Bon Natural Life Limited CIK Number: 0001816815 Dear Sir or Madam: We have read Form 6-K dated October 18, 2022 of Bon Natural Life Limited. (the ?Registrant?) and are in agreement with the statements contained therein as it pertains to our firm. We have no basis to agree or

October 18, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi?an Hi-Tech Zone, Xi?an, China People?s

October 3, 2022 CORRESP

Joe Laxague

Joe Laxague Partner [email protected] Mason Allen Of Counsel [email protected] VIA EDGAR October 03, 2022 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Attn: Abby Adams Re: Bon Natural Life Limited Registration Statement on Form F-3 Filed August 26, 2022 File No. 333-267116 Dear Ms. Adams: We write on behalf of Bon Natural Life Limited (the ?Company?)

October 3, 2022 F-3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter)

Registration No. 333-267116 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 25F,

August 26, 2022 EX-FILING FEES

Filing Fee Table (incorporated by reference to Exhibit 107 of our Registration Statement on Form F-3 (File No. 333- 267116), initially filed with the SEC on August 26, 2022)

Exhibit 107 Calculation of Filing Fee Tables F-3 (Form Type) Bon Natural Life Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity(1) Ordinary Shares of Common Stock, $0.

August 26, 2022 F-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter)

Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 25F, Rongcheng Yungu, Kej

August 1, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) 25F, Rongcheng Yungu, Keji 3rd Road Xi?an Hi-Tech Zone, Xi?an, China People?s

August 1, 2022 EX-99.1

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) March 31, 2022 September 30, 2021 As Of March 31, 2022 September 30, 2021 ASSETS CURRENT ASSETS Cash $ 1,609,079 $ 1,903,867 Short-term investments 132,114 1,703,314 Accounts receivable, net 7,534,786 6,152,807 Inventories, net 2,143,385 1,596,492 Advance to suppliers, net 3,187,116 4,094,312 A

June 30, 2022 EX-99.1

Bon Natural Life Limited Announces Change to Board Composition

EXHIBIT 99.1 Bon Natural Life Limited Announces Change to Board Composition Xian, China, June 30, 2022 ? Bon Natural Life Limited (Nasdaq: BON) (?BON? or the ?Company?), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the appointment of Jeffrey Guzy, as a new independent Director to its Board of Directors and as Chair of th

June 30, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China People?

June 30, 2022 EX-10.1

Director Service Agreement

Exhibit 10.1 BON NATURAL LIFE LIMITED DIRECTOR SERVICE AGREEMENT This Director Service Agreement (the ?Agreement?) is made and entered into as of June 28th, 2022, by and between Bon Natural Life Limited, a Cayman Islands corporation (the ?Company?), and Jeffrey J. Guzy, an individual (the ?Director?). I. SERVICES A. Service on the Board of Directors. The Director has been appointed as an Independe

June 22, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China People?

February 3, 2022 EX-99.2

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS

Exhibit 99.2 ??????????2021???????? - ????39.9%???2549??? - 2021?????????460?????????????0.68?? ?????2022?2?2????????????????????????BON?????????????????????????????????????????????????????????2021?9?30????????? 2021?????? ? ????2549?????2020????1820??????39.9%? ? ????2020????520??????710???????36.7%? ? ?????2020????140?????130????????3.2%??43,344??? ? ??????????????2021?2020?????449,972?362,187??

February 3, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China Peo

February 3, 2022 EX-99.1

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 Bon Natural Life Bon Natural Life Limited Announces Record-Setting Full Fiscal Year 2021 Results - Revenue increased by 39.9% to $25.49 million. - Delivered full fiscal year 2021 net income of $4.6 million, or $0.68 per diluted share. Xian, China, February 2, 2021 ? Bon Natural Life Limited (Nasdaq: BON) (?BON? or the ?Company?), one of the leading bio-ingredient solutions providers i

January 31, 2022 20-F

Form 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

January 31, 2022 EX-99.1

Bon Natural Life Limited Announces FY2021 Earnings Release Date and Webcast

Exhibit 99.1 Bon Natural Life Limited Announces FY2021 Earnings Release Date and Webcast ? Earnings to be released before market opens on Monday, January 31, 2022 Xian, China, January 28, 2022 ? Bon Natural Life Limited (Nasdaq: BON) (?BON? or the ?Company?), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its FY2021 earnings re

January 31, 2022 EX-21.1

Significant subsidiaries of the Registrant(3)

EX-21.1 2 ex21-1.htm EXHIBIT 21.1 Significant Subsidiaries of Bon Natural Life Limited Direct Subsidiary Tea Essence Limited (Hong Kong); 100% owned by Bon Natural Life Limited Wholly Foreign-Owned Enterprises Xi’an Cell and Molecule Information Technology Limited (PRC); 100% owned by Tea Essence Limited Xi’an Youpincui Biotechnology Co., Ltd. (PRC); 100% owned by Tea Essence Limited PRC Subsidiar

January 31, 2022 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China Peop

November 5, 2021 6-K

Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China Peo

August 17, 2021 EX-99.2

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.2 Bon Natural Life Bon Natural Life Limited Announces Record First Half-Year Revenue and Net Income -1H-2021 Revenue increases by 63.6% to $11.7 million- Xian, China, August 17, 2021 ? Bon Natural Life Limited (Nasdaq: BON) (?BON? or the ?Company?), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year fi

August 17, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number 001-40517 B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China Peopl

August 17, 2021 EX-99.1

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) As of March 31, 2021 September 30, 2020 ASSETS CURRENT ASSETS Cash $ 1,040,607 $ 53,106 Accounts receivable, net 8,869,747 5,771,008 Inventories, net 1,446,516 1,016,442 Advance to suppliers, net 1,894,359 3,491,145 Deferred initial public offering costs 984,162 510,079 Prepaid expenses and oth

July 6, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China People?

July 6, 2021 EX-99.1

Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility

Exhibit 99.1 Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility Key Milestone To Increase Production Capacity Xian, China, July 6, 2021 ? Bon Natural Life Limited (Nasdaq: BON) (?BON? or the ?Company?), a leading bio-ingredient solutions provider in the natural, health and personal care industries, today announced that they have received the certificate

June 25, 2021 424B4

BON NATURAL LIFE LIMITED 2,200,000 Ordinary Shares INITIAL PUBLIC OFFERING

424B4 1 form424b4.htm Filed Pursuant to Rule 424(b)(4) Registration No. 333-251182 PROSPECTUS BON NATURAL LIFE LIMITED 2,200,000 Ordinary Shares INITIAL PUBLIC OFFERING This is the initial public offering of Bon Natural Life Limited. We are offering 2,200,000 ordinary shares, par value US$0.0001 per share (the “Shares”) at a price of US$5.00 per Share. Prior to this offering, there has been no pub

June 24, 2021 EX-1.1

Underwriting Agreement

EX-1.1 2 ex1-1.htm Exhibit 1.1 BON NATURAL LIFE LIMITED UNDERWRITING AGREEMENT June 23, 2021 US Tiger Securities, Inc. 437 Madison Avenue, 27th Floor New York, NY 10022 Newbridge Securities Corporation 1200 North Federal Highway, Suite 400 Boca Raton, FL 33432 R. F. Lafferty & Co., Inc. 40 Wall Street, 29th Floor New York, NY 10005 As Representatives of the Underwriters named on Schedule A hereto

June 24, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number 001-40517 BON

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number 001-40517 BON NATURAL LIFE LIMITED (Translation of registrant?s name into English) C601, Gazelle Valley, No.69 Jinye Road. Xi?an Hi-tech Zone, Xi?an, China People?

June 24, 2021 EX-99.1

Bon Natural Life Limited Announces Pricing of Upsized $11 Million Initial Public Offering

Exhibit 99.1 Bon Natural Life Limited Announces Pricing of Upsized $11 Million Initial Public Offering Xian, China, June 23, 2021 ? Bon Natural Life Limited (Nasdaq: BON) (?BON? or the ?Company?), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the pricing of its firm commitment initial public offering of 2,200,000 ordinary

June 23, 2021 F-1MEF

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter)

As filed with the U.S. Securities and Exchange Commission on June 23, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction of incorporation or organization) (Primary S

June 22, 2021 F-1/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 Amendment No. 4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter)

As filed with the U.S. Securities and Exchange Commission on June 22, 2021 Registration No. 333-251182 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 Amendment No. 4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction

June 21, 2021 8-A12B

Form 8-A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BON NATURAL LIFE LIMITED (Exact name of registrant as specified in its charter) Cayman Islands Not applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identifi

June 21, 2021 CORRESP

June 21, 2021

June 21, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Office of Life Sciences 100 F St., NE Washington, D.C. 20549 Re: Bon Natural Life Limited Registration Statement on Form F-1 (File No. 333-251182) Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933

June 21, 2021 CORRESP

VIA EDGAR

VIA EDGAR June 21, 2021 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Division of Corporation Finance Washington, D.

June 11, 2021 FWP

FWP

May 14, 2021 EX-1.1

Form of Underwriting Agreement

EX-1.1 2 ex1-1.htm Exhibit 1.1 BON NATURAL LIFE LIMITED UNDERWRITING AGREEMENT [ ], 2021 US Tiger Securities, Inc. 437 Madison Avenue, 27th Floor New York, NY 10022 Newbridge Securities Corporation 1200 North Federal Highway Suite 400 Boca Raton, FL 33432 R. F. Lafferty & Co., Inc. 40 Wall Street, 19th Floor New York, NY 10005 As Representatives of the Underwriters named on Schedule A hereto Ladie

May 14, 2021 F-1/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter)

As filed with the U.S. Securities and Exchange Commission on May 14, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction of incorporation or organizat

May 14, 2021 EX-4.1

Registrant’s Specimen Certificate for Ordinary Shares (incorporated by reference to Exhibit 4.1 of our Registration Statement on Form F-1 (File No. 333- 251182), as amended, initially filed with the SEC on December 7, 2020)

Exhibit 4.1

March 30, 2021 F-1/A

-

As filed with the U.S. Securities and Exchange Commission on March 30, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction of incorporation or organiz

March 30, 2021 CORRESP

VIA EDGAR

VIA EDGAR March 30, 2021 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

January 7, 2021 CORRESP

VIA EDGAR

VIA EDGAR January 7, 2021 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

January 7, 2021 F-1/A

-

As filed with the U.S. Securities and Exchange Commission on January 7, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction of incorporation or organi

December 7, 2020 EX-3.1

Memorandum and Articles of Association of the Registrant, as currently in effect

Exhibit 3.1

December 7, 2020 EX-10.4

English translation of Supplemental Shares Pledge Agreement among Xi’an CMIT, Xi’an App-Chem and the shareholders of Xi’an App-Chem dated June 10, 2020

Exhibit 10.4

December 7, 2020 EX-99.1

Consent of Director Nominee Lawrence W. Leighton

Exhibit 99.1 CONSENT TO BE NAMED AS DIRECTOR In connection with the Registration Statement on Form F-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Bon Natural Life Limited (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with the U.S. Securities and

December 7, 2020 EX-10.6

English translations of Spousal Consents granted by the shareholders of Xi’an App-Chem

EXhibit 10.6

December 7, 2020 EX-10.1

English translation of Exclusive Service Agreement between Xi’an CMIT and Xi’an App-Chem dated May 28, 2020

Exhibit 10.1

December 7, 2020 EX-10.12

Director Service Agreement with James E. Burns

Exhibit 10.12

December 7, 2020 EX-10.8

Labor Contract between Xi’an App-Chem and Zhenchao Li

Exhibit 10.8 Labor contract Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Address: Room C601, Entrepreneurship Research and Development Park, No. 69, Jinye Road, Xi’an Hi-Tech Industries Development Zone, China Telephone:029-88346301 Post Code: 710077 Party B: Zhenchao Li ID Number: 610404196503210833 Address: Ziwei Yonghe Fang Telephone: 13309232083 Post Code: 710086 Tel: 029-88346301 Labor Contra

December 7, 2020 F-1

-

As filed with the U.S. Securities and Exchange Commission on December 7, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction of incorporation or organization) (Primar

December 7, 2020 EX-10.5

English translation of Proxy Agreement and Power of Attorney among Xi’an CMIT, Xi’an App-Chem and the shareholders of Xi’an App-Chem dated May 28, 2020

Exhibit 10.5

December 7, 2020 EX-10.9

Director Service Agreement with Christopher Constable

Exhibit 10.9

December 7, 2020 EX-99.4

Waiver Request

Exhibit 99.4 Bon Natural Life Limited C601,Gazelle Valley, No.69 Jinye Rd. Xi’an Hi-tech Zone, Xi’an, China VIA EDGAR December , 2020 Division of Corporation Finance U.S. Securities and Exchange Commission Attn: Deanna Virginio Re: Bon Natural Life Limited Registration Statement on Form F-1 (File No. 333-) Request for Waiver and Representation under Item 8.A.4 of Form 20-F Ladies and Gentlemen: Th

December 7, 2020 EX-10.7

Labor Contract between Xi’an App-Chem and Yongwei Hu

Exhibit 10.7 Labor contract Party A: Xi’an App-Chem Bio (Tech) Co., Ltd Address: Room C601, Entrepreneurship Research and Development Park, No. 69, Jinye Road, Xi’an Hi-Tech Industries Development Zone, China Telephone:029-88346301 Post Code: 710077 Party B: Yongwei Hu ID Number: 610103197108023635 Address: No. 34, Caotan Road, Lianhu District Telephone: 18066610998 Post Code: Labor Contract No.:

December 7, 2020 EX-10.3

English translation of Shares Pledge Agreement among Xi’an CMIT, Xi’an App-Chem and the shareholders of Xi’an App-Chem dated May 28, 2020

Exhibit 10.3

December 7, 2020 EX-99.2

Consent of Director Nominee Christopher Constable

Exhibit 99.2 CONSENT TO BE NAMED AS DIRECTOR In connection with the Registration Statement on Form F-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Bon Natural Life Limited (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with the U.S. Securities and

December 7, 2020 EX-10.2

English translation of Exclusive Option Agreement among Xi’an CMIT, Xi’an App-Chem and the shareholders of Xi’an App-Chem dated May 28, 2020

Exhibit 10.2

December 7, 2020 EX-10.14

Code of Business Conduct and Ethics

Exhibit 10.14 BON NATURAL LIFE LIMITED CODE OF BUSINESS CONDUCT AND ETHICS Bon Natural Life Limited (the “Company”) has adopted the following Code of Business Conduct and Ethics (this “Code”) for directors, executive officers and employees of the Company. This Code is intended to focus the directors, executive officers and employees on areas of ethical risk, provide guidance to directors, executiv

December 7, 2020 EX-10.10

Xi’an App-Chem Shareholder Powers of Attorney

Exhibit 10.10

December 7, 2020 EX-10.14

English translation of Property Lease Agreement for Weinan Raw Materials and Ingredients Production Site

Exhibit 10.14 Property Lease Agreement Party A (Leaser): 陕西荔北绿健生物制品厂 (Shaanxi Libei Lvjian Biological Products Co., Ltd.) Party B (Lessee): 西安应化生物技术有限公司 (Xi’an App-Chem Bio (Tech) Co., Ltd.) Individually a Party and collectively the Parties. Subject to the principle of mutual benefit and common development, after fairly and friendly negotiation, the Parties reach the following agreements as to the

December 7, 2020 EX-21.1

Significant subsidiaries and consolidated affiliated entities of the Registrant

Exhibit 21.1 Significant Subsidiaries and Consolidated Affiliated Entities of Bon Natural Life Limited Direct Subsidiary Tea Essence Limited (Hong Kong); 100% owned by Bon Natural Life Limited Wholly Foreign-Owned Enterprise Xi’an Cell and Molecule Information Technology Limited (PRC); 100% owned by Tea Essence Limited Consolidated Variable Interest Entity Xi’an App-Chem Bio(Tech) Co., Ltd. (PRC)

December 7, 2020 EX-10.11

Loan Agreement

Exhibit 10.11

December 7, 2020 EX-99.3

Consent of Director Nominee James Edward Burns

Exhibit 99.3 CONSENT TO BE NAMED AS DIRECTOR In connection with the Registration Statement on Form F-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Bon Natural Life Limited (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with the U.S. Securities and

December 7, 2020 EX-10.13

Director Service Agreement with Lawrence W. Leighton

Exhibit 10.13

September 21, 2020 DRSLTR

Mark E. Crone

Mark E. Crone Managing Partner [email protected] Joe Laxague Of Counsel [email protected] VIA EDGAR September 21, 2020 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Attn: Deanna Virginio Re: Bon Natural Life Limited Draft Registration Statement on Form F-1 Filed July 13, 2020 CIK No. 0001816815 Dear Ms. Virginio: We write on behalf of Bon Natural Life

September 21, 2020 EX-99.1

CONSENT TO BE NAMED AS DIRECTOR

EX-99.1 5 filename5.htm Exhibit 99.1 CONSENT TO BE NAMED AS DIRECTOR In connection with the Registration Statement on Form F-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Bon Natural Life Limited (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with

September 21, 2020 EX-10.7

Labor contract

Exhibit 10.7 Labor contract Party A: Xi’an App-Chem Bio (Tech) Co., Ltd Address: Room C601, Entrepreneurship Research and Development Park, No. 69, Jinye Road, Xi’an Hi-Tech Industries Development Zone, China Telephone:029-88346301 Post Code: 710077 Party B: Yongwei Hu ID Number: 610103197108023635 Address: No. 34, Caotan Road, Lianhu District Telephone: 18066610998 Post Code: Labor Contract No.:

September 21, 2020 EX-99.3

CONSENT TO BE NAMED AS DIRECTOR

Exhibit 99.3 CONSENT TO BE NAMED AS DIRECTOR In connection with the Registration Statement on Form F-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Bon Natural Life Limited (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with the U.S. Securities and

September 21, 2020 EX-99.2

CONSENT TO BE NAMED AS DIRECTOR

EX-99.2 6 filename6.htm Exhibit 99.2 CONSENT TO BE NAMED AS DIRECTOR In connection with the Registration Statement on Form F-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Bon Natural Life Limited (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with

September 21, 2020 EX-10.14

Property Lease Agreement

Exhibit 10.14 Property Lease Agreement Party A (Leaser): 陕西荔北绿健生物制品厂 (Shaanxi Libei Lvjian Biological Products Co., Ltd.) Party B (Lessee): 西安应化生物技术有限公司 (Xi’an App-Chem Bio (Tech) Co., Ltd.) Individually a Party and collectively the Parties. Subject to the principle of mutual benefit and common development, after fairly and friendly negotiation, the Parties reach the following agreements as to the

September 21, 2020 EX-10.8

Labor contract

EX-10.8 3 filename3.htm Exhibit 10.8 Labor contract Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. Address: Room C601, Entrepreneurship Research and Development Park, No. 69, Jinye Road, Xi’an Hi-Tech Industries Development Zone, China Telephone:029-88346301 Post Code: 710077 Party B: Zhenchao Li ID Number: 610404196503210833 Address: Ziwei Yonghe Fang Telephone: 13309232083 Post Code: 710086 Tel: 0

September 21, 2020 DRS/A

-

This is a confidential draft submission to the U.S. Securities and Exchange Commission on September 21, 2020 and is not being filed under the Securities Act of 1933, as amended. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in

July 13, 2020 EX-10.4

EX-10.4

Exhibit 10.4

July 13, 2020 EX-10.2

EX-10.2

EX-10.2 6 filename6.htm Exhibit 10.2

July 13, 2020 EX-10.7

EX-10.7

Exhibit 10.7

July 13, 2020 EX-21.1

Significant Subsidiaries and Consolidated Affiliated Entities of Bon Natural Life Limited

EX-21.1 19 filename19.htm Exhibit 21.1 Significant Subsidiaries and Consolidated Affiliated Entities of Bon Natural Life Limited Direct Subsidiary Tea Essence Limited (Hong Kong); 100% owned by Bon Natural Life Limited Wholly Foreign-Owned Enterprise Xi’an Cell and Molecule Information Technology Limited (PRC); 100% owned by Tea Essence Limited Consolidated Variable Interest Entity Xi’an App-Chem

July 13, 2020 EX-10.8

EX-10.8

EX-10.8 12 filename12.htm Exhibit 10.8

July 13, 2020 EX-10.14

BON NATURAL LIFE LIMITED CODE OF BUSINESS CONDUCT AND ETHICS

EX-10.14 18 filename18.htm Exhibit 10.14 BON NATURAL LIFE LIMITED CODE OF BUSINESS CONDUCT AND ETHICS Bon Natural Life Limited (the “Company”) has adopted the following Code of Business Conduct and Ethics (this “Code”) for directors, executive officers and employees of the Company. This Code is intended to focus the directors, executive officers and employees on areas of ethical risk, provide guid

July 13, 2020 EX-10.10

EX-10.10

Exhibit 10.10

July 13, 2020 EX-10.13

EX-10.13

Exhibit 10.13

July 13, 2020 EX-10.1

EX-10.1

Exhibit 10.1

July 13, 2020 EX-10.11

EX-10.11

Exhibit 10.11

July 13, 2020 DRS

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bon Natural Life Limited (Exact name of Registrant as specified in its charter) Cayman Islands 2833 Not applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificat

July 13, 2020 EX-10.5

EX-10.5

Exhibit 10.5

July 13, 2020 EX-10.12

EX-10.12

Exhibit 10.12

July 13, 2020 EX-10.9

EX-10.9

Exhibit 10.9

July 13, 2020 EX-10.3

EX-10.3

Exhibit 10.3

July 13, 2020 EX-3.1

EX-3.1

EX-3.1 2 filename2.htm Exhibit 3.1

July 13, 2020 EX-10.6

EX-10.6

EXhibit 10.6

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista